The Cambridge Depersonalization Scale is widely considered the most reliable measure of the disorder. Patients are asked to ...

The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, "Fulfilling the Promise of Noninvasive Brain ...

Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced the initiation of a Phase 2 ...

Dr. Jacob Buinewicz, a Philadelphia-area general psychiatrist, added a patient portal to his new website in late 2024DOYLESTOWN, Pa., Jan. 06, 2025 (GLOBE NEWSWIRE) -- As a general psychiatrist ...

Discover how personalized care is revolutionizing bipolar I management. explore new treatments offering hope for lasting ...

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

Under Kansas City's Wellness Court, staff and supporting agencies will be at the same table in meetings, discussing a ...

A new study has found that early treatment with lithium can restore brain function in certain mouse models of autism spectrum disorder (ASD). | Drug Discovery And Development ...

Lithium, a drug commonly used to treat bipolar disorder and depression, has emerged as a potential therapy for autism ...

Lithium, a drug widely used for bipolar disorder, may also treat autism spectrum disorder (ASD), according to new research.

A groundbreaking clinical trial has revealed that nerve-stimulating therapy can bring significant improvements to people with ...